Cellebrite DI (CLBT) Stock Overview
Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for CLBT from our risk checks.
CLBT Community Fair Values
Create NarrativeSee what 33 others think this stock is worth. Follow their fair value or set your own to get alerts.
Cellebrite DI Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$19.30 |
52 Week High | US$26.30 |
52 Week Low | US$13.10 |
Beta | 1.29 |
1 Month Change | 10.73% |
3 Month Change | 32.74% |
1 Year Change | 6.28% |
3 Year Change | 337.64% |
5 Year Change | n/a |
Change since IPO | n/a |
Recent News & Updates
What Cellebrite DI Ltd.'s (NASDAQ:CLBT) 26% Share Price Gain Is Not Telling You
Sep 09Cellebrite: Long-Term Growth Is Now Much Clearer (Rating Upgrade)
Sep 08Earnings Beat: Cellebrite DI Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 18Recent updates
Shareholder Returns
CLBT | US Software | US Market | |
---|---|---|---|
7D | 1.6% | -1.8% | -1.2% |
1Y | 6.3% | 26.6% | 15.1% |
Return vs Industry: CLBT underperformed the US Software industry which returned 26.2% over the past year.
Return vs Market: CLBT underperformed the US Market which returned 15.5% over the past year.
Price Volatility
CLBT volatility | |
---|---|
CLBT Average Weekly Movement | 4.7% |
Software Industry Average Movement | 7.9% |
Market Average Movement | 6.5% |
10% most volatile stocks in US Market | 17.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CLBT has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CLBT's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 1,167 | Tom Hogan | www.cellebrite.com |
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company’s DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations.
Cellebrite DI Ltd. Fundamentals Summary
CLBT fundamental statistics | |
---|---|
Market cap | US$4.75b |
Earnings (TTM) | -US$150.95m |
Revenue (TTM) | US$436.73m |
Is CLBT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CLBT income statement (TTM) | |
---|---|
Revenue | US$436.73m |
Cost of Revenue | US$68.24m |
Gross Profit | US$368.50m |
Other Expenses | US$519.45m |
Earnings | -US$150.95m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
Earnings per share (EPS) | -0.62 |
Gross Margin | 84.38% |
Net Profit Margin | -34.56% |
Debt/Equity Ratio | 0% |
How did CLBT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/10/15 19:20 |
End of Day Share Price | 2025/10/15 00:00 |
Earnings | 2025/06/30 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cellebrite DI Ltd. is covered by 10 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Tomer Zilberman | BofA Global Research |
Tyler Radke | Citigroup Inc |
Jeffrey Van Rhee | Craig-Hallum Capital Group LLC |